Cite
MLA Citation
Ursula A. Matulonis et al.. “Olaparib maintenance therapy in patients with platinum‐sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.” Cancer, vol. 122, no. 12, 2016, pp. 1844–1852. http://access.bl.uk/ark:/81055/vdc_100032499815.0x000060